1996
DOI: 10.1042/bj3160575
|View full text |Cite
|
Sign up to set email alerts
|

Long-term effect of cyclic AMP on N-glycosylation is caused by an increase in the activity of the cis-prenyltransferase

Abstract: Previously we have shown that long-term pretreatment of JEG-3 choriocarcinoma cells with 8-bromo-cAMP increases the capacity for N-glycosylation that was caused by an 8-10-fold enlargement of the dolichol pyrophosphoryl oligosaccharide (Dol-PP-oligosaccharide) pool [Konrad and Merz (1994) J. Biol. Chem. 269, 8659-8666]. The factors involved in the effect of cAMP on synthesis of Dol-PP-oligosaccharide are investigated here. The GlcNAc transfer to dolichol phosphate (Dol-P) was found to be unaffected by pretreat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
6
0

Year Published

2001
2001
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(7 citation statements)
references
References 49 publications
1
6
0
Order By: Relevance
“…Similarly, the adenylate cyclase activator forskolin [40] increased surface expression of CD59 as well. This was in accordance with the notion that high levels of cyclic AMP lead to higher activity of DHDDS and thus increased Dol levels [41,42].…”
Section: Therapeutics Targeting Dolicholsupporting
confidence: 92%
“…Similarly, the adenylate cyclase activator forskolin [40] increased surface expression of CD59 as well. This was in accordance with the notion that high levels of cyclic AMP lead to higher activity of DHDDS and thus increased Dol levels [41,42].…”
Section: Therapeutics Targeting Dolicholsupporting
confidence: 92%
“…De novo biosynthesis is initiated by the sequential addition of 12-17 isoprene units from isopentenyl pyrophosphate to farnesyl pyrophosphate catalyzed by ER-associated cis-isoprenyltransferases. The elongation stage is a key rate-controlling event in Dol-P synthesis Konrad and Merz, 1996). In the current view of the pathway the long-chain allylic pyrophosphate intermediate is then dephosphorylated, presumably on the cytoplasmic surface of the ER.…”
Section: Discussionmentioning
confidence: 99%
“…Regulation of glycosylation can be tested with activators and inhibitors. Cyclic adenosine monophosphate (cAMP) has been shown to increase N-glycosylation capacity due to enlargement of the dolichol pyrophosphoryl oligosaccharide [ 20 22 ]. In contrast, tunicamycin completely blocks protein glycosylation by inhibition of the formation of N-acetylglucosamine-lipid intermediates [ 23 – 26 ], which results in decreased activity of membrane transporters because the membrane proteins remain localized in intracellular compartments due to decreased translocation to the cell surface membrane [ 27 ].…”
Section: Introductionmentioning
confidence: 99%